RNA Disease Diagnostics Announces Inaugural Joint Meeting of Expanded Board of Directors and Advisory Board RNA Disease Diagnostics Inc. New York, New York, UNITED STATES
BALTIMORE, May 11, 2021 (GLOBE NEWSWIRE) RNA Disease Diagnostics, Inc. (RNADD), a company developing a best-in-class molecular diagnostics platform for infectious disease detection, announced today that it held an inaugural joint meeting of its Board of Directors and Advisory Board on May 10, 2021. The newly expanded Board of Directors and Advisory Board will work alongside the leadership team to advance RNADD s proprietary
Antisense RNA diagnostic platform to prevent the transmission of infectious diseases. We are honored to have such a highly skilled, well-regarded group of industry veterans to comprise our Board of Directors and Advisory Board, said Allan Oberman, co-Founder and Chairman of RNADD. Representing decades of experience in healthcare, finance, business, and more,